路透 - 视频

版本: US | UK | IN | CN | JP

video

Breakingviews TV: Array factor

2019年 6月 18日 星期二 - 03:31

Pfizer is buying Array BioPharma for $11 billion, a 62% premium. It’s Big Pharma buying another smallish biotech, but in this case, Array’s backstory is a mix of skill, law and luck, as Rob Cyran explains.

▲ 隐藏详情

显示详情

Pfizer is buying Array BioPharma for $11 billion, a 62% premium. It’s Big Pharma buying another smallish biotech, but in this case, Array’s backstory is a mix of skill, law and luck, as Rob Cyran explains.

分享到  - 微信
路透中文网

Breakingviews TV: Array factor

2019年 6月 18日 星期二 - 03:31